An Observational Study to Learn More About the Long-Term Responses to Treatment With Regorafenib in Patients With Metastatic Colorectal Cancer in the United States

NCT06029010 · clinicaltrials.gov ↗
COMPLETED
Status
2326
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bayer